Market›Health Care›Biotechnology›Biotechnology
LONGEVITY HEALTH HLD

XAGE

$0.31Sep 23, 2021 – Apr 24, 2026
Health CareBiotechnology$1M
MVM
+$0.0M
TD Variance
6.529

Every news event mapped to its market reaction — 22 events, 56 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-01-02+120.1%M&ASeeking AlphaCarmell's earning potential swells with Elevai acquisition
2025-07-15+118.6%newsTokenistWhy did XAGE Stock Surge in Today’s Premarket Trading? - Tokenist
2025-07-14+112.9%M&AYahoo FinanceLongevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction - Yahoo Finance
2025-04-14+41.7%M&ASeeking AlphaLongevity Health to combine with 20/20 BioLabs in all-stock deal
2024-12-24+41.4%newsSeeking AlphaCarmell announces PIPE investment, shares up more than 20%
2023-07-27+27.7%M&ASeeking AlphaCarmell jumps on deal to merge with Axolotl Biologix
2023-07-27+27.7%newsSeeking AlphaMNK, AAOI and TUP are among pre market gainers
2025-07-16-25.2%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Longevity Health Holdings, Inc. (XAGE) - Zacks Investment Research
2025-05-12-21.6%newsSeeking AlphaLongevity Health to conduct reverse stock split
2025-05-12-21.6%newsYahoo FinanceLongevity Health Holdings, Inc. Announces Reverse Stock Split - Yahoo Finance
2025-03-11-19.1%newsCoinCodexLongevity Health Holdings Inc. (XAGE) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2024-03-20+17.1%newsSeeking AlphaCarmell looks to sell Axolotl Biologix
2026-03-26-16.1%newsBusiness WireLongevity Health and Innovaccer Announce Enterprise AI Center of Excellence After Achieving $1M Cost Savings
2023-11-29-12.6%executiveSeeking AlphaCarmell CEO buys shares worth over $15.5k - filing
2024-07-29+11.4%executiveSeeking AlphaCarmell appoints Kendra Bracken-Ferguson as CEO
2026-04-08+10.5%executiveStock TitanCEO-linked entity for Longevity Health (NASDAQ: XAGE) buys 689,656 shares in open market - Stock Titan
2026-04-08+10.5%executiveStock TitanXAGE (Longevity Health) CEO reports 689,656 indirect shares on Form 3 - Stock Titan
2026-03-17+5.9%M&AGlobeNewswireLongevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
2023-07-13-1.7%M&ASeeking AlphaSPAC Alpha Healthcare III shareholders approve Carmell merger
2023-06-27-1.2%M&ASeeking AlphaSPAC Alpha Healthcare III signs merger LOI with second allogeneic company
2023-01-05-0.8%newsSeeking AlphaCarmell Therapeutics to go public via Alpha Healthcare
2024-05-10-0.1%newsSeeking AlphaCarmell Corporation files to sell 1.33M shares for holders
tickerdossier.comtickerdossier.substack.com